Petros Pharm Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 1,027 | 392 | 991 | 1,801 | 1,458 |
| Operating Income | -1,027 | -392 | -991 | -1,801 | -1,458 |
| Other Income | 40 | 55 | 68 | -241 | 259 |
| Pre-tax Income | -987 | -337 | -923 | -2,041 | -1,200 |
| Net Income Continuous | -987 | -337 | -923 | -2,041 | -1,200 |
| Net Income Discontinuous | 0 | -7,474 | N/A | 14,948 | -1,061 |
| Net Income | $-987 | $-7,811 | $-923 | $12,907 | $-2,260 |
| EPS Basic Total Ops | -0.03 | 9.13 | -0.03 | -1.29 | -9.37 |
| EPS Basic Continuous Ops | -0.03 | 8.28 | -0.03 | -1.58 | -8.46 |
| EPS Basic Discontinuous Ops | N/A | 0.85 | N/A | 0.29 | -0.91 |
| EPS Diluted Total Ops | -0.03 | 9.13 | -0.03 | -1.29 | -9.37 |
| EPS Diluted Continuous Ops | -0.03 | 8.28 | -0.03 | -1.58 | -8.46 |
| EPS Diluted Discontinuous Ops | N/A | 0.85 | N/A | 0.29 | -0.91 |
| EPS Diluted Before Non-Recurring Items | -0.03 | N/A | -0.03 | -1.58 | -8.46 |
| EBITDA(a) | $-1,027 | $-392 | $-991 | $-1,801 | $-1,458 |